Navigation Links
Smith & Nephew Introduces New Biologic to Speed Healing
Date:3/5/2008

We are proud to be able to offer this new technology to our customers. The product application is universal because platelets naturally aid in the healing process of multiple tissue types," said Mark Augusti, president of Smith & Nephew Orthopaedic Trauma & Clinical Therapies. "CAPTION is also a great example of what great things two cutting-edge teams can accomplish for the good of our customers and their patients."

The CAPTION system joins the company's biologic portfolio, which includes the EXOGEN 4000+(TM) ultrasound bone healing system and SUPARTZ(R) treatment the world's number one joint fluid therapy for pain reduction of the knee.

(TM) Trademark of Smith & Nephew.

SUPARTZ is a registered trademark of the Seikagaku Corporation.

About us

Smith & Nephew is a global medical technology business, specializing in Orthopaedic Trauma & Clinical Therapies, Orthopaedic Reconstruction, Endoscopy and Advanced Wound Management products. Smith & Nephew is a global leader in arthroscopy and advanced wound management and is one of the leading global orthopaedics companies.

Smith & Nephew is dedicated to helping improve people's lives. The Company prides itself on the strength of its relationships with its surgeons and professional healthcare customers, with whom its name is synonymous with high standards of performance, innovation and trust. The Company operates in 32 countries around the world. Annual sales in 2007 were nearly $3.4 billion.

Forward-Looking Statements

This press release contains certain "forward-looking statements" within the meaning of the US Private Securities Litigation Reform Act of 1995. In particular, statements regarding planned growth in our business and in our trading margins discussed under "Outlook" are forward-looking statements as are discussions of our product pipeline. These statements, as well as the phrases "aim", "plan", "intend", "anticipate", "well-placed", "believe", "estimate"
'/>"/>

SOURCE Smith & Nephew, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Smith & Nephew Announces Breakthrough VERILAST(TM) Technology
2. Robert H. Smith Feeding the Future with $15 Million Gift to Hebrew University of Jerusalem
3. Smith & Nephew Wins OXINIUM(TM) Approval in Japan
4. Smith & Nephew Orthopaedic Reconstruction Global Management Team Announced
5. Celebrity Cook Paula Deen and Husband Michael Groover Bring Smithfield Foods Helping Hungry Homes(TM) Tour To Feed New Orleans Families
6. EUSA Pharma Out-Licenses Preclinical-Stage Human Antibody to GlaxoSmithKline for up to $44 Million Plus Royalties
7. Celebrity Cook Paula Deen and Husband Michael Groover Bring Smithfield Foods Helping Hungry Homes(TM) Tour to L.A.
8. Amira Pharmaceuticals and GlaxoSmithKline Enter Global Agreement for FLAP Inhibitor Program
9. Senator Sam Brownback and Rep. Chris Smith to Speak at Blogs for Life
10. Law Offices of Howard G. Smith Announces Class Action Lawsuit Against Security Capital Assurance Ltd.
11. AUDIO from Medialink and GlaxoSmithKline: Get Ready to Get Moving to a New You in the New Year
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/14/2014)... orphaned by HIV/AIDS in South Africa may provide insight ... behavior issues in other areas of the world, which ... that could lead to successful interventions. , A ... United Nations mentions that due to the HIV/AIDS pandemic, ... African, children are at an increased risk for mental ...
(Date:4/14/2014)... A new study shows that moderate to severe ... risk of stroke, cancer and death. , Results of ... to severe obstructive sleep apnea were four times more ... times more likely to have a stroke (HR = ... (HR = 3.4), and 2.5 times more likely to ...
(Date:4/14/2014)... Dallas study involving serious youth offenders, the answer to one ... seven years: "How long do you think you,ll live?", According ... offending over time., Author Dr. Alex Piquero said the study ... of them offend at very high rates and commit more ... much later in life offend much less., "In a lot ...
(Date:4/14/2014)... with symptoms increasing dramatically during some of the most important ... has found. , Depressive symptoms increased on average by 68 ... young men, who were around 25 years old when they ... their children. The results of the study were published April ... is the first to identify when young fathers are at ...
(Date:4/14/2014)... Lower weight babies and babies who aren,t breastfed ... risk of developing chronic inflammation and related health ... study. , "There were good reasons to hypothesize ... inflammation in adulthood," says Thomas McDade (Northwestern University), ... in the Child & Brain Development program. "It ...
Breaking Medicine News(10 mins):Health News:Researchers identify children with emotional behavior difficulties 2Health News:Researchers identify children with emotional behavior difficulties 3Health News:Study links severe sleep apnea to increased risk of stroke, cancer and death 2Health News:UT Dallas study: Youth who fail to envision future commit more crimes 2Health News:Young dads at high risk of depression, too 2Health News:Low birth weight, less breastfeeding create later health risks 2
... Art of Living Foundation of spiritual leader Sri Sri ... by 2008 that will be an "amalgamation of science ... Ravi Shankar Vidya Mandir (SSRVM) Trust, the educational wing ... memorandum of understanding with Ashok Tripathy, the secretary of ...
... a medical and health university to promote the study //of ... ,"The government will soon start the process of ... the university," Vishnoi told IANS, adding that the idea came ... ,"The need for introducing subjects like yoga and ...
... chances of getting cardiovascular, pulmonary, neurological, and endocrine ... according to a research published in the November ... Medicine. ,"This work is yet another ... relationships between mental and physical health," said Caroline ...
... papilloma virus (HPV), is the virus that causes cervical cancer ... uterus, known as cervix. It is transmitted sexually.// ... Plc's has introduced Cervarix, both vaccines, clinically been proven to ... potential are likely to be welcomed in rich countries but ...
... oral contraceptives taken on a long term basis to do away ... both safe and effective.The study// was published in the journal” Contraception”.,There ... the number of menstrual periods to four in a year. This ... to do away with menstrual periods altogether. ,"It ...
... the mutated form of a gene called Palladin causes ... the// disease is so deadly. The research project was ... professor of medicine, and supported by The Lustgarten Foundation, ... cancer is usually a fatal diagnosis. One of the ...
Cached Medicine News:Health News:Schizophrenics At Greater Risk Of Developing Chronic Diseases 2Health News:Vaccines For Cervical Cancer Will Soon Be Available In Developing Nations 2Health News:Team Discovers a Gene That Causes Familial Pancreatic Cancer 2Health News:Team Discovers a Gene That Causes Familial Pancreatic Cancer 3
(Date:1/15/2014)... 2014  Echo Therapeutics, Inc. (Nasdaq: ... its Symphony® CGM System as a non-invasive, wireless ... Robert F. Doman , Executive Chairman and Interim ... Noble Financial Capital Markets, Tenth Annual Equity Conference. ... corporate presentation to prospective corporate partners and investors ...
(Date:1/15/2014)... , Jan. 15, 2014  Valeant Pharmaceuticals International, Inc. ... that the applicable waiting period under the Hart-Scott-Rodino Antitrust ... previously announced tender offer by its indirect wholly-owned subsidiary, ... shares of common stock of Solta Medical, Inc. (NASDAQ: ... $2.92 per share, net to the seller in cash, ...
(Date:1/14/2014)... Mass. , Jan. 14, 2014 ... HTWR ), a leading innovator of less invasive, ... treatment of advanced heart failure, today announced that ... 2013 will be approximately $53 million, bringing expected ... "Our full-year revenue growth of 87% for ...
Breaking Medicine Technology:Echo Therapeutics to Present at the Noble Financial Capital Markets' Tenth Annual Equity Conference 2Echo Therapeutics to Present at the Noble Financial Capital Markets' Tenth Annual Equity Conference 3Valeant Pharmaceuticals Announces Receipt Of Antitrust Clearance For Its Previously Announced Acquisition Of Solta Medical, Inc. 2Valeant Pharmaceuticals Announces Receipt Of Antitrust Clearance For Its Previously Announced Acquisition Of Solta Medical, Inc. 3HeartWare International Announces Preliminary Fourth Quarter 2013 Revenues 2HeartWare International Announces Preliminary Fourth Quarter 2013 Revenues 3HeartWare International Announces Preliminary Fourth Quarter 2013 Revenues 4
... March 13, 2012  American Capital, Ltd. (Nasdaq: ... million, $20 million together with its affiliates, in the ... a medical device company focused on women,s health.   ... portfolio company Halt Medical as it continues to grow ...
... 2012  Janssen Research & Development, LLC today announced ... of ZYTIGA® (abiraterone acetate) plus prednisone for the ... metastatic castration-resistant prostate cancer (CRPC) who have not ... an international, randomized, double-blind, placebo controlled study that included ...
Cached Medicine Technology:American Capital and its Affiliates Invest $20 Million in Portfolio Company Halt Medical 2Study Unblinded: ZYTIGA® (abiraterone acetate) Plus Prednisone for Asymptomatic or Mildly Symptomatic Chemotherapy-Naive Patients with Metastatic Castration-Resistant Prostate Cancer 2Study Unblinded: ZYTIGA® (abiraterone acetate) Plus Prednisone for Asymptomatic or Mildly Symptomatic Chemotherapy-Naive Patients with Metastatic Castration-Resistant Prostate Cancer 3Study Unblinded: ZYTIGA® (abiraterone acetate) Plus Prednisone for Asymptomatic or Mildly Symptomatic Chemotherapy-Naive Patients with Metastatic Castration-Resistant Prostate Cancer 4Study Unblinded: ZYTIGA® (abiraterone acetate) Plus Prednisone for Asymptomatic or Mildly Symptomatic Chemotherapy-Naive Patients with Metastatic Castration-Resistant Prostate Cancer 5Study Unblinded: ZYTIGA® (abiraterone acetate) Plus Prednisone for Asymptomatic or Mildly Symptomatic Chemotherapy-Naive Patients with Metastatic Castration-Resistant Prostate Cancer 6
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: